Chronic Prostatitis Does NOT Cause False-Positive Prostate Biopsy Results for Cancer
Chronic prostatitis can cause false-positive PSA tests and suspicious imaging findings that lead to biopsy, but it does not cause a false-positive biopsy result showing cancer when cancer is not present. The biopsy itself remains the definitive diagnostic test that distinguishes between inflammation and malignancy 1.
Understanding the Distinction
What Prostatitis Actually Affects
Chronic prostatitis creates diagnostic confusion at the screening level, not the biopsy interpretation level:
- PSA elevation: Prostatitis may cause PSA velocity to rise, leading to unnecessary biopsies 1
- Imaging false-positives: Inflammation appears as suspicious lesions on MRI (high PI-RADS scores) that mimic cancer 2, 3
- Physical exam findings: Inflammatory nodules on digital rectal examination can feel like cancer 4
However, when tissue is obtained and examined microscopically, pathologists can definitively distinguish chronic inflammation from adenocarcinoma. The biopsy shows what is actually present: either cancer cells or inflammatory cells, not both when only one exists.
The Clinical Problem: Unnecessary Biopsies
The real issue is that 2 out of 3 men with elevated PSA do not have cancer 1, and many of these false-positive PSA results are due to benign conditions including prostatitis. This leads to:
- Unnecessary biopsies with associated risks (infection, bleeding, pain)
- Patient anxiety
- Healthcare costs
Specific Histologic Findings in False-Positive Imaging
When MRI suggests cancer but biopsy shows no malignancy, the tissue often reveals 3:
- Increased stromal tissue (statistically significant predictor, p=0.02)
- Basal cell hyperplasia (independent predictor, p=0.038)
- Chronic inflammation with atrophic glands
- The combination of high inflammation, high stroma, and basal cell hyperplasia strongly associates with false-positive MRI (p=0.001)
Practical Management Algorithm
When PSA is Elevated with Known or Suspected Prostatitis:
Consider antibiotic therapy first 1, 5: Treat the prostatitis and repeat PSA measurements after treatment
- Many men see PSA return to normal range after antimicrobial therapy
- Use repeated measurements to minimize biologic variability
Use biomarker refinement before proceeding to biopsy in PSA 3-10 ng/mL range 6:
- Percent free PSA (<10% highly suspicious; >25% can observe)
- PHI (>35 suspicious)
- PCA3 (>35 suspicious)
- 4Kscore
- ConfirmMDx for repeat biopsy consideration
If biopsy is performed, ensure extended pattern (≥12 cores) 7, 8
When Biopsy Shows Only Inflammation:
- This is a true-negative result, not a false-positive for cancer
- Follow PSA trends over time
- Consider repeat biopsy only if PSA continues rising or other risk factors emerge
- Multiparametric MRI can help identify missed lesions in repeat biopsy scenarios 7
Critical Caveat
The association between chronic prostatitis and prostate cancer risk is complex 9, 10. Recent large-scale data shows men with prostatitis have increased subsequent cancer diagnosis rates (HR 2.99, p<0.001), with acute prostatitis showing even higher association (HR 3.82) 9. This likely reflects:
- Detection bias (more screening in symptomatic men)
- Shared inflammatory pathways
- Increased medical surveillance
Therefore, while prostatitis doesn't cause false-positive biopsy results, men with prostatitis require appropriate follow-up as they may have genuinely elevated cancer risk or simply increased detection rates.
Bottom Line for Clinical Practice
When a biopsy shows chronic prostatitis without cancer, trust that result. The pathologist has made the correct diagnosis. Your concern should focus on whether the elevated PSA or suspicious imaging that prompted the biopsy warrants continued surveillance or repeat sampling, not whether the inflammation is masquerading as cancer on the pathology report.